KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $1.8 million.

  • Staar Surgical's Gains from Investment Securities fell 3391.71% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 3391.71%. This contributed to the annual value of $2.8 million for FY2024, which is 676.81% up from last year.
  • Staar Surgical's Gains from Investment Securities amounted to $1.8 million in Q3 2025, which was down 3391.71% from $2.4 million recorded in Q2 2025.
  • Staar Surgical's Gains from Investment Securities' 5-year high stood at $126.7 million during Q4 2021, with a 5-year trough of $39000.0 in Q3 2023.
  • In the last 5 years, Staar Surgical's Gains from Investment Securities had a median value of $2.6 million in 2021 and averaged $12.6 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 9845.5% in 2023, then skyrocketed by 707435.9% in 2024.
  • Staar Surgical's Gains from Investment Securities (Quarter) stood at $126.7 million in 2021, then plummeted by 80.34% to $24.9 million in 2022, then tumbled by 40.02% to $14.9 million in 2023, then tumbled by 81.57% to $2.8 million in 2024, then tumbled by 32.86% to $1.8 million in 2025.
  • Its Gains from Investment Securities stands at $1.8 million for Q3 2025, versus $2.4 million for Q2 2025 and $2.6 million for Q1 2025.